Source:http://linkedlifedata.com/resource/pubmed/id/11478427
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-7-31
|
pubmed:abstractText |
Atrial natriuretic peptide (ANP) is an important regulator of sodium metabolism and indirectly of blood pressure. Evidence has accumulated that ANP regulates sodium metabolism through a cascade of steps involving an increase in the level of cGMP, activation of cGMP-dependent protein kinase (PKG), and inhibition of renal tubular Na+, K+-ATPase activity. One of the major substrates for PKG is DARPP-32. In the present study we observed that ANP does not induce natriuresis in mice that lack DARPP-32. In contrast, there was a 4-fold increase in urinary sodium excretion following ANP administration to wild type mice. ANP as well as Zaprinast, a selective inhibitor of cGMP phosophodiesterase, inhibited renal Na+, K+-ATPase activity in wild type mice but had no such effect in mice lacking DARPP-32. Mean arterial blood pressure, measured in conscious animals, was significantly increased in DARPP-32 deficient mice as compared to wild type mice. The results confirm that DARPP-32 acts as a third messenger in the ANP signaling pathway in renal tissue and suggest an important role of DARPP-32 in the maintenance of normal blood pressure.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine and cAMP-Regulated...,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1064-1963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
449-60
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11478427-Animals,
pubmed-meshheading:11478427-Atrial Natriuretic Factor,
pubmed-meshheading:11478427-Blood Pressure,
pubmed-meshheading:11478427-Body Weight,
pubmed-meshheading:11478427-Cyclic GMP,
pubmed-meshheading:11478427-Disease Models, Animal,
pubmed-meshheading:11478427-Dopamine and cAMP-Regulated Phosphoprotein 32,
pubmed-meshheading:11478427-Male,
pubmed-meshheading:11478427-Mice,
pubmed-meshheading:11478427-Mice, Knockout,
pubmed-meshheading:11478427-Natriuresis,
pubmed-meshheading:11478427-Nerve Tissue Proteins,
pubmed-meshheading:11478427-Organ Size,
pubmed-meshheading:11478427-Phenotype,
pubmed-meshheading:11478427-Phosphoproteins,
pubmed-meshheading:11478427-Sodium
|
pubmed:year |
2001
|
pubmed:articleTitle |
Increased blood pressure and loss of anp-induced natriuresis in mice lacking DARPP-32 gene.
|
pubmed:affiliation |
Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|